Lumos Reaches FebriDx CLIA Waiver Study Enrolment Milestone
Filed with ASX · · 3 pages · English
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
Earlier from Lumos Diagnostics
- Lumos Reaches Recruitment Milestone in FebriDx Study
- Lumos Secures Sixth US Medicare Reimbursement for FebriDx
- Lumos Secures Fifth US Medicare Reimbursement for FebriDx
- Lumos Advances FebriDx Sales with iMedical Purchase Order
- Lumos Secures Further US Medicare Reimbursement for FebriDx
Later from Lumos Diagnostics
- Pause in Trading
- Suspension from Quotation
- Lumos Signs Pivotal US FebriDx Agreement
- Reinstatement to Quotation
- Lumos Signs Binding Term Sheet for A$5M Loan Facility
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics